A pooled analysis of the cardiac events in the trastuzumab adjuvant trials.

导出 OA

翻译打印收藏纠错

第一作者： Evandro,de Azambuja

第一单位： Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Boulevard de Waterloo, 121 (7th Floor), 1000, Brussels, Belgium. evandro.azambuja@bordet.be.

作者： Evandro,de Azambuja ^[1] ; Noam,Ponde ^[2] ; Marion,Procter ^[3] ; Priya,Rastogi ^[4] ; Reena S,Cecchini ^[5] ; Matteo,Lambertini ^[6] ; Karla,Ballman ^[2] ; Alvaro Moreno,Aspitia ^[7] ; Dimitrios,Zardavas ^[6] ; Lise,Roca ^[8] ; Richard D,Gelber ^[9] ; Martine,Piccart-Gebhart ^[10] ; Thomas,Suter ^[11]

作者单位： Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Boulevard de Waterloo, 121 (7th Floor), 1000, Brussels, Belgium. evandro.azambuja@bordet.be. ^[1] Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Boulevard de Waterloo, 121 (7th Floor), 1000, Brussels, Belgium. ^[2] AC Camargo Cancer Center, Sao Paulo, Brazil. ^[3] Frontier Science (Scotland), Kincraig, UK. ^[4] NRG Oncology, and The University of Pittsburgh Medical Center, Pittsburgh, PA, USA. ^[5] NRG Oncology, and the University of Pittsburgh, Pittsburgh, PA, USA. ^[6] IRCCS Ospedale Policlinico San Martino and University of Genova, GENOVA, Italy. ^[7] Mayo Clinic, Jacksonville, FL, USA. ^[8] Breast International Group (BIG), Brussels, Belgium. ^[9] Institut Regional du Cancer Montpellier Val d'Aurelle, Montpellier, France. ^[10] Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health, and Frontier Science and Technology Research Foundation, Boston, MA, USA. ^[11] University Hospital Bern, Bern, Switzerland. ^[12]

关键词 Breast cancer Cardiotoxicity LVEF Trastuzumab